Estradiol/nomegestrol continuous

Drug Profile

Estradiol/nomegestrol continuous

Alternative Names: E2/Nomac continuous; EMM 220066; Nomac/E2 continuous

Latest Information Update: 02 Jun 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Theramex SAM
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 02 Jun 2006 Discontinued - Phase-III for Menopausal syndrome in Europe (PO)
  • 08 Jan 2002 Discontinued-II for Postmenopausal osteoporosis in Europe (PO)
  • 15 Nov 2001 This product is available for licensing in the US and Japan (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top